53 results

• Tepezza Hearing Loss Side Effects May Be Reduced at Lower Doses: Case Report

  April 3, 2023

  Irvin Jackson

  A new case study found that cutting the dosage in half helped resolve many Tepezza hearing loss problems and other adverse side effects linked to the thyroid eye disease drug.

• MDL Sought for Tepezza Lawsuits Over Hearing Problems Linked To Thyroid Eye Disease Treatment

  March 27, 2023

  Irvin Jackson

  A second motion to create a Tepezza lawsuits MDL has been filed, calling for the cases to be consolidated in a California federal court for pretrial proceedings.

• Lawsuit Over Tepezza and Hearing Loss Filed Against Horizon Therapeutics

  March 23, 2023

  Irvin Jackson

  A Tepezza lawsuit filed by a Georgia woman blames infusions of the thyroid eye disease treatment for permanent hearing loss damage.

• Tepezza Hearing Damage Lawsuit Filed Against Makers of Thyroid Eye Disease Drug

  February 16, 2023

  Irvin Jackson

  A Tepezza hearing damage lawsuit claims a woman suffered permanent hearing loss due to the side effects of the thyroid eye disease drug.

• Drug Maker Files Motion to Dismiss Tepezza Lawsuit Over Hearing Loss Warnings

  February 13, 2023

  Irvin Jackson

  Horizon Pharmaceuticals is asking a federal judge to dismiss all Tepezza lawsuits over hearing loss injuries, claiming they are preempted by federal law.

• Tepezza Hearing Loss Claimants Seek To Consolidate 10 Lawsuits Against Horizon Therapeutics Filed in Northern District of Illinois

  January 18, 2023

  Irvin Jackson

  A group of plaintiffs are calling for Tepezza hearing loss lawsuits to be consolidated before one Northern Illinois federal judge for pretrial proceedings.

• Investors File Lawsuit To Prevent Acquisition of Tepezza Manufacturer Horizon Therapeutics

  January 9, 2023

  Irvin Jackson

  Two investors have filed lawsuits to stop the acquisition of Tepezza manufacturer Horizon Therapeutics, claiming the company is hiding material financial projections from shareholders who must approve the deal.

• Horizon Therapeutics Acquired for Nearly $30B Amid Growing Threat of Tepezza Lawsuit Payouts

  December 15, 2022

  Irvin Jackson

  Despite the threat of having to eventually pay Tepezza lawsuit payouts, Amgen has acquired the drug's manufacturer, Horizon Pharmaceuticals for nearly $30 billion.

• Tepezza Side Effects May Increase Risk of Hyperglycemia: Study

  November 29, 2022

  Irvin Jackson

  A new study found more than half of patients who took Tepezza experienced some form of hyperglycemia, which could be a particularly serious risk to patients with diabetes.

• Tepezza Users Often Require Second Treatment Course for Thyroid Eye Disease

  November 22, 2022

  Irvin Jackson

  The findings of a new study suggest five percent of Tepezza users require a second treatment course of the thyroid eye disease drug, raising questions as to whether those patients face an even higher risk of hearing loss than other Tepezza users.